X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8763) 8763
Newsletter (183) 183
Book / eBook (27) 27
Newspaper Article (5) 5
Book Chapter (4) 4
Conference Proceeding (3) 3
Magazine Article (3) 3
Publication (3) 3
Dissertation (2) 2
Streaming Video (2) 2
Web Resource (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7118) 7118
animals (4476) 4476
antineoplastic agents - pharmacology (3779) 3779
oncology (2840) 2840
cancer (2812) 2812
female (2561) 2561
mice (2546) 2546
antineoplastic agents - therapeutic use (2091) 2091
pharmacology & pharmacy (2003) 2003
male (1978) 1978
cell line, tumor (1826) 1826
immunotherapy (1687) 1687
chemotherapy (1487) 1487
apoptosis (1334) 1334
immunology (1286) 1286
tumors (1167) 1167
neoplasms - drug therapy (1119) 1119
research (1030) 1030
antineoplastic agents (1000) 1000
middle aged (1000) 1000
care and treatment (979) 979
expression (907) 907
aged (872) 872
apoptosis - drug effects (829) 829
treatment outcome (816) 816
antineoplastic agents, immunological - pharmacology (799) 799
adult (778) 778
cell proliferation - drug effects (770) 770
health aspects (769) 769
antimitotic agents (763) 763
therapy (762) 762
analysis (755) 755
antineoplastic agents - administration & dosage (708) 708
cytotoxicity (708) 708
biochemistry & molecular biology (678) 678
antineoplastic agents, immunological - therapeutic use (675) 675
metastasis (674) 674
mice, inbred balb c (661) 661
medicine, research & experimental (652) 652
cancer therapies (642) 642
medicine & public health (630) 630
melanoma (630) 630
neoplasms - immunology (630) 630
cell biology (622) 622
immunologic factors - pharmacology (605) 605
hematology (604) 604
adjuvants, immunologic - pharmacology (585) 585
antineoplastic combined chemotherapy protocols - therapeutic use (579) 579
drug therapy (574) 574
in-vitro (568) 568
cells (566) 566
dose-response relationship, drug (554) 554
mice, inbred c57bl (549) 549
proteins (546) 546
antineoplastic agents, phytogenic - pharmacology (537) 537
activation (536) 536
tumor cells, cultured (535) 535
lymphocytes (534) 534
immunotherapy - methods (521) 521
antineoplastic agents - adverse effects (520) 520
xenograft model antitumor assays (516) 516
antineoplastic agents - chemistry (498) 498
cell survival - drug effects (487) 487
dendritic cells (485) 485
disease models, animal (481) 481
breast cancer (473) 473
signal transduction - drug effects (466) 466
antibodies, monoclonal - therapeutic use (463) 463
medicine (462) 462
pharmacology/toxicology (461) 461
gene expression (457) 457
flow cytometry (449) 449
clinical trials as topic (447) 447
antibodies, monoclonal - pharmacology (442) 442
survival (442) 442
molecular targeted therapy (433) 433
research article (429) 429
neoplasms - pathology (421) 421
toxicity (419) 419
cancer research (414) 414
immunologic factors - therapeutic use (407) 407
clinical trials (405) 405
combined modality therapy (402) 402
inhibition (399) 399
chemistry, medicinal (398) 398
t cells (398) 398
in-vivo (396) 396
t-cells (394) 394
rats (390) 390
growth (389) 389
breast-cancer (386) 386
medical research (383) 383
monoclonal antibodies (383) 383
pharmacology (382) 382
neoplasms - therapy (379) 379
signal transduction (376) 376
cytokines (374) 374
drug resistance, neoplasm (372) 372
killer cells, natural - immunology (371) 371
multidisciplinary sciences (366) 366
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8884) 8884
Japanese (80) 80
Chinese (61) 61
Russian (53) 53
German (29) 29
French (12) 12
Polish (12) 12
Italian (8) 8
Hungarian (6) 6
Norwegian (4) 4
Czech (3) 3
Ukrainian (3) 3
Spanish (2) 2
Dutch (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Carbohydrate polymers, ISSN 0144-8617, 11/2016, Volume 153, pp. 663 - 678
•This review presented naturally occurring polysaccharides from tea materials (TPS).•Main methods for extraction and purification were... 
Extraction | Bioactivity | Future perspectives | Purification | Structure | Tea polysaccharide | PU-ERH TEA | DIABETIC MICE | POLYMER SCIENCE | CHEMICAL-CHARACTERIZATION | CHEMISTRY, ORGANIC | OOLONG TEA | VITRO ANTIOXIDANT ACTIVITY | ACIDIC POLYSACCHARIDE | CAMELLIA-SINENSIS FLOWER | ZIYANG GREEN TEA | ACTIVITY IN-VITRO | CHEMISTRY, APPLIED | WATER-SOLUBLE POLYSACCHARIDE | Camellia sinensis - chemistry | Plant Extracts - chemistry | Anti-Infective Agents - isolation & purification | Adjuvants, Immunologic - pharmacology | Antioxidants - chemistry | Plant Extracts - pharmacology | Anti-Infective Agents - pharmacology | Humans | Adjuvants, Immunologic - chemistry | Polysaccharides - isolation & purification | Anti-Infective Agents - chemistry | Polysaccharides - chemistry | Adjuvants, Immunologic - isolation & purification | Antineoplastic Agents, Phytogenic - chemistry | Plant Extracts - isolation & purification | Hypoglycemic Agents - chemistry | Antioxidants - pharmacology | Anti-Obesity Agents - isolation & purification | Polysaccharides - pharmacology | Hypoglycemic Agents - pharmacology | Hypoglycemic Agents - isolation & purification | Anti-Obesity Agents - chemistry | Animals | Antioxidants - isolation & purification | Chemical Fractionation | Antineoplastic Agents, Phytogenic - pharmacology | Anti-Obesity Agents - pharmacology | Tea - chemistry | Antineoplastic Agents, Phytogenic - isolation & purification | Polysaccharides | Polyphenols | Yuan (China) | Functional foods
Journal Article
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 2018, Volume 13, Issue 4, pp. e0191926 - e0191926
CTLA-4 and CD28 exemplify a co-inhibitory and co-stimulatory signaling axis that dynamically sculpts the interaction of antigen-specific T cells with... 
UNTREATED MELANOMA | CYTOKINE RELEASE ASSAYS | LUNG-CANCER | IN-VITRO | MEDIATED CYTOTOXICITY | CRYSTAL-STRUCTURE | MULTIDISCIPLINARY SCIENCES | REGULATORY T-CELLS | CTLA-4 | ANTITUMOR ACTIVITIES | NIVOLUMAB PLUS IPILIMUMAB | Antineoplastic Agents, Immunological - toxicity | Epitope Mapping | Adjuvants, Immunologic - pharmacology | Antineoplastic Agents, Immunological - pharmacokinetics | Cricetulus | Cancer Vaccines - pharmacology | Humans | Immunoglobulin G - toxicity | Macaca fascicularis | Antineoplastic Agents, Immunological - chemistry | T-Lymphocytes, Regulatory - immunology | Adjuvants, Immunologic - pharmacokinetics | Neoplasms - therapy | Immunity, Cellular - drug effects | Adjuvants, Immunologic - chemistry | Immunoglobulin G - pharmacology | CHO Cells | Amino Acid Sequence | Immunoglobulin G - chemistry | Cells, Cultured | Models, Molecular | Adjuvants, Immunologic - toxicity | CTLA-4 Antigen - immunology | Antineoplastic Agents, Immunological - pharmacology | T-Lymphocytes, Regulatory - drug effects | Animals | Lymphocyte Activation - drug effects | Neoplasms - immunology | Antibody Formation - drug effects | CTLA-4 Antigen - antagonists & inhibitors | Toxicology | Pharmacology, Experimental | Research | Immunoglobulin G | Analysis | CD86 antigen | PD-1 protein | Lung cancer | Antibodies | Biochemistry | Lymphocytes T | CD28 antigen | Immunity | CTLA-4 protein | Lymphocytes | Immunotherapy | Combined vaccines | Primates | Repressing | Medical research | Immunoglobulins | Cytokines | Immunoregulation | Immunomodulation | Research & development--R&D | CD80 antigen | Pharmacology | T cell receptors | Chemical compounds | Signaling | Antigen-presenting cells | Biomarkers | Index Medicus | Research & development | R&D
Journal Article
Leukemia & lymphoma, ISSN 1029-2403, 2018, Volume 59, Issue 12, pp. 2792 - 2800
...). Capable of inducing durable remissions, these agents also modulate the immune system. Both ibrutinib and idelalisib abrogate the tumor-supporting microenvironment... 
the humoral immune response | T-cell mediated immunity | Lymphoid leukemia | signaling therapies | B-CELL RECEPTOR | 3-KINASE P110-DELTA | OPEN-LABEL | HEMOLYTIC-ANEMIA | BRUTONS TYROSINE KINASE | TUMOR-MICROENVIRONMENT | ONCOLOGY | SUPPRESSOR-CELLS | HEMATOLOGY | T-CELLS | TEC FAMILY KINASES | IBRUTINIB TREATMENT | Pyrazoles - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Infections - chemically induced | Antineoplastic Combined Chemotherapy Protocols - pharmacology | T-Lymphocytes - drug effects | Purines - therapeutic use | Immunosuppressive Agents - pharmacology | Leukemia, Lymphocytic, Chronic, B-Cell - immunology | Quinazolinones - pharmacology | Infections - immunology | Pyrazoles - pharmacology | Autoimmune Diseases - epidemiology | Tumor Microenvironment - drug effects | Infections - epidemiology | Purines - pharmacology | Autoimmune Diseases - immunology | Treatment Outcome | Pyrimidines - pharmacology | Tumor Microenvironment - immunology | B-Lymphocytes - drug effects | B-Lymphocytes - immunology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Cell Communication - drug effects | T-Lymphocytes - immunology | Protein Kinase Inhibitors - pharmacology | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Quinazolinones - therapeutic use | Autoimmune Diseases - chemically induced | Autoimmunity - drug effects | The Humoral Immune Response | Signaling therapies | Lymphoid Leukemia | T-Cell Mediated Immunity
Journal Article
Blood, ISSN 1528-0020, 2011, Volume 118, Issue 18, pp. 4771 - 4779
Journal Article